Science Explorer Interactive view Map
Research facility · Nedlands · Australia

Linear Clinical Research

linear.org.auROR OpenAlex
Research works
74
▲ 79% vs 2013–17
Citations
888
12.0 per fractional work
Top-10% rate
24.8%
record average 16.5%
Open access
48%
world 28%

Not ranked overall: Linear Clinical Research is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.17× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.49× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 8.16× its world share, 2 worksImmunology and Micro…Neuroscience: 1.10× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.89× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.22× its world share, 0 worksChemistryEngineering: 0.04× its world share, 0 worksEngineeringMaterials Science: 0.10× its world share, 0 worksMaterials ScienceHealth Professions: 0.02× its world share, 0 worksHealth ProfessionsMedicine: 3.64× its world share, 19 worksMedicineVeterinary: 5.26× its world share, 0 worksVeterinaryArts and Humanities: 0.21× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 0.39× its world share, 0 worksEconomics, Econometr…Psychology: 0.26× its world share, 0 worksPsychologySocial Sciences: 0.10× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.2×. Every wedge is a field page.

Which keywords describe research at Linear Clinical Research?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Rituximab, Lymphoma, Cancer Immunotherapy, Prognostic Factors, Tumor Microenvironment, PET Imaging, Immunotherapy and Therapeutic Targets.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Rituximab4▲ 95×2 topics
  2. Lymphoma4▲ 81×2 topics
  3. Cancer Immunotherapy3▲ 69×3 topics
  4. Prognostic Factors3▲ 22×8 topics
  5. PET Imaging2▲ 50×4 topics
  6. Tumor Microenvironment2▲ 19×7 topics
  7. Immunotherapy2▲ 12×12 topics
  8. Therapeutic Targets2▲ 55×4 topics
  9. Chemotherapy2▲ 12×12 topics
  10. Chronic Lymphocytic Leukemia2▲ 162×1 topic
  11. Classification2▲ 16×2 topics
  12. Genomic Aberrations2▲ 162×1 topic
  13. Molecular Profiling2▲ 72×2 topics
  14. Genetic Pathogenesis2▲ 130×1 topic
  15. Hodgkin's Lymphoma2▲ 130×1 topic
  16. Immune Checkpoint Blockade2▲ 58×1 topic
  17. PD-1 and PD-L12▲ 58×1 topic
  18. Tumor Regression2▲ 60×2 topics
  19. CAR T Cells2▲ 82×1 topic
  20. Chimeric Antigen Receptor2▲ 82×1 topic
  21. Inflammation2▲ 2.8×17 topics
  22. Monoclonal Antibodies2▲ 61×2 topics
  23. Targeted Therapy2▲ 24×4 topics
  24. Cancer1▲ 3.7×19 topics
  25. Cancer Therapy1▲ 9.1×10 topics
  26. Fc Receptors1▲ 93×1 topic
  27. Glycosylation1▲ 46×2 topics
  28. Therapeutic Antibodies1▲ 73×1 topic
  29. Breast Cancer1▲ 19×5 topics
  30. Immunity1▲ 9.9×5 topics
  31. Clinical Trials1▲ 5.5×5 topics

Which research topics does Linear Clinical Research publish most on?

By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research.

Chronic Lymphocytic Leukemia Research: 2 fractional worksLymphoma Diagnosis and Treatment: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksLung Cancer Treatments and Mutations: 1 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksCNS Lymphoma Diagnosis and Treatment: 0 fractional worksPhagocytosis and Immune Regulation: 0 fractional works
GeneticsPathology and Forensic MedicineOncologyRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Chronic Lymphocytic Leukemia Research Genetics 2 works
  2. 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
  4. 4 CAR-T cell therapy research Oncology 2 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  6. 6 Immunotherapy and Immune Responses Immunology 1 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  8. 8 HER2/EGFR in Cancer Research Oncology 1 works
  9. 9 CNS Lymphoma Diagnosis and Treatment Neurology 0 works
  10. 10 Phagocytosis and Immune Regulation Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.0%not open52.0%

World: 28% of research is openly available.

with international co-authors58.6%domestic only41.4%

World: 19% is written across borders.

How has Linear Clinical Research's research output changed?

Output in 2018–2022 was 79% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Nedlands

All research institutions in Nedlands

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.